• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

相似文献

1
Pain as a risk factor for substance use: a qualitative study of people who use drugs in British Columbia, Canada.疼痛作为物质使用的风险因素:对加拿大不列颠哥伦比亚省吸毒者的定性研究。
Harm Reduct J. 2018 Jul 5;15(1):35. doi: 10.1186/s12954-018-0241-y.
2
Negotiating structural vulnerability following regulatory changes to a provincial methadone program in Vancouver, Canada: A qualitative study.加拿大温哥华省级美沙酮项目监管变更后应对结构脆弱性的探讨:一项定性研究
Soc Sci Med. 2015 May;133:168-76. doi: 10.1016/j.socscimed.2015.04.008. Epub 2015 Apr 7.
3
Pain Among High-Risk Patients on Methadone Maintenance Treatment.接受美沙酮维持治疗的高危患者的疼痛
J Pain. 2015 Sep;16(9):887-94. doi: 10.1016/j.jpain.2015.06.003. Epub 2015 Jun 21.
4
Chronic pain management among people who use drugs: A health policy challenge in the context of the opioid crisis.慢性疼痛管理在药物使用者中:阿片类药物危机背景下的健康政策挑战。
Int J Drug Policy. 2019 Sep;71:150-156. doi: 10.1016/j.drugpo.2019.03.023. Epub 2019 Apr 8.
5
Zoned Out: "NIMBYism", addiction services and municipal governance in British Columbia.分区失效:不列颠哥伦比亚省的“邻避主义”、成瘾服务和市政治理。
Int J Drug Policy. 2013 Nov;24(6):e61-5. doi: 10.1016/j.drugpo.2013.04.001. Epub 2013 May 13.
6
"Everybody looks at it as drug use instead of pain management": Experiences of chronic pain and its management among older people living with HIV who use drugs in Vancouver, British Columbia.“大家都把它看作是吸毒,而不是疼痛管理”:不列颠哥伦比亚省温哥华的老年艾滋病毒感染者药物使用者的慢性疼痛及其管理的体验。
Drug Alcohol Depend. 2024 Sep 1;262:111399. doi: 10.1016/j.drugalcdep.2024.111399. Epub 2024 Jul 14.
7
Primary Care Physicians' Views about Prescribing Methadone to Treat Opioid Use Disorder.基层医疗医生对开具美沙酮治疗阿片类物质使用障碍的看法。
Subst Use Misuse. 2018 Jan 28;53(2):344-353. doi: 10.1080/10826084.2017.1325376. Epub 2017 Aug 30.
8
Association of Methadone Treatment With Substance-Related Hospital Admissions Among a Population in Canada With a History of Criminal Convictions.在加拿大有犯罪记录人群中,美沙酮治疗与物质相关住院治疗之间的关联。
JAMA Netw Open. 2019 Mar 1;2(3):e190595. doi: 10.1001/jamanetworkopen.2019.0595.
9
The risk environments of people who use drugs accessing two harm reduction centers in Tehran, Iran: A qualitative study.伊朗德黑兰的两家减少伤害中心中使用毒品者的风险环境:一项定性研究。
Int J Drug Policy. 2019 Jan;63:90-96. doi: 10.1016/j.drugpo.2018.11.013. Epub 2018 Dec 2.
10
Medication-assisted therapy for opioid-dependent incarcerated populations in New Mexico: statewide efforts to increase access.新墨西哥州监禁的阿片类药物依赖者的药物辅助治疗:全州范围内努力增加获取途径。
Subst Abus. 2012;33(1):76-84. doi: 10.1080/08897077.2011.611455.

引用本文的文献

1
Reconceptualizing Advocacy: A Novel Model for Nursing Theory and Practice.重新构想倡导:护理理论与实践的新模式。
Nurs Inq. 2025 Jul;32(3):e70036. doi: 10.1111/nin.70036.
2
Discharge with insufficient or inappropriate care in Canada's EDs: overcoming the challenges for people who use drugs.加拿大急诊科存在护理不足或不适当的出院情况:应对吸毒者面临的挑战。
CJEM. 2025 May 20. doi: 10.1007/s43678-025-00944-z.
3
Attending to Marginalization in The Chronic Pain Literature: A Scoping Review.关注慢性疼痛文献中的边缘化问题:一项范围综述
Can J Pain. 2024 Mar 28;8(2):2335500. doi: 10.1080/24740527.2024.2335500. eCollection 2024.
4
Denial of prescription pain medication among people who use drugs in Vancouver, Canada.加拿大温哥华的药物使用者拒绝开处方止痛药。
Harm Reduct J. 2024 Mar 28;21(1):72. doi: 10.1186/s12954-024-00956-5.
5
Prevalence, correlates, and quality-of-life outcomes of major or persistent pain among women living with HIV in Metro Vancouver, Canada.加拿大温哥华都会区 HIV 感染者中主要或持续疼痛的流行率、相关因素和生活质量结局。
Harm Reduct J. 2024 Jan 13;21(1):10. doi: 10.1186/s12954-023-00859-x.
6
Paths Forward for Clinicians Amidst the Rise of Unregulated Clinical Decision Support Software: Our Perspective on NarxCare.在不受监管的临床决策支持软件兴起之际,临床医生的前进之路:我们对 NarxCare 的看法。
J Gen Intern Med. 2024 Apr;39(5):858-862. doi: 10.1007/s11606-023-08528-2. Epub 2023 Nov 14.
7
"As safe as possible": a qualitative study of opioid withdrawal and risk behavior among people who use illegal opioids.“尽可能安全”:一项针对非法使用阿片类药物者戒断症状和风险行为的定性研究。
Harm Reduct J. 2023 Oct 27;20(1):158. doi: 10.1186/s12954-023-00893-9.
8
The impact of relaxing restrictions on take-home doses during the COVID-19 pandemic on program effectiveness and client experiences in opioid agonist treatment: a mixed methods systematic review.放松 COVID-19 大流行期间美沙酮维持治疗计划中带药回家剂量限制对项目效果和服务对象体验的影响:一项混合方法系统评价。
Subst Abuse Treat Prev Policy. 2023 Sep 30;18(1):56. doi: 10.1186/s13011-023-00564-9.
9
"The Box Has Become an Indispensable Part of My Life": A Case Study of Victoria Cannabis Buyers Club and its Consumption Space.“盒子已成为我生活中不可或缺的一部分”:维多利亚大麻购买俱乐部及其消费空间的案例研究
Contemp Drug Probl. 2023 Sep;50(3):426-450. doi: 10.1177/00914509231183147. Epub 2023 Jun 22.
10
Cannabis use to manage opioid cravings among people who use unregulated opioids during a drug toxicity crisis.在药物中毒危机期间,使用未经监管的阿片类药物的人使用大麻来控制阿片类药物的渴望。
Int J Drug Policy. 2023 Sep;119:104113. doi: 10.1016/j.drugpo.2023.104113. Epub 2023 Jul 21.

本文引用的文献

1
Association Between Prescription Drug Monitoring Programs and Nonfatal and Fatal Drug Overdoses: A Systematic Review.处方药物监测项目与非致命性和致命性药物过量之间的关联:一项系统性综述。
Ann Intern Med. 2018 Jun 5;168(11):783-790. doi: 10.7326/M17-3074. Epub 2018 May 8.
2
Association Between US State Medical Cannabis Laws and Opioid Prescribing in the Medicare Part D Population.美国州医疗大麻法律与医疗保险处方中阿片类药物开方之间的关联。
JAMA Intern Med. 2018 May 1;178(5):667-672. doi: 10.1001/jamainternmed.2018.0266.
3
Association of Medical and Adult-Use Marijuana Laws With Opioid Prescribing for Medicaid Enrollees.医疗用大麻和成人使用大麻法律与医疗补助计划参保者开阿片类药物处方的关联。
JAMA Intern Med. 2018 May 1;178(5):673-679. doi: 10.1001/jamainternmed.2018.1007.
4
Chronic pain and opioid misuse: a review of reviews.慢性疼痛与阿片类药物滥用:系统综述的综述。
Subst Abuse Treat Prev Policy. 2017 Aug 15;12(1):36. doi: 10.1186/s13011-017-0120-7.
5
Fentanyl in the US heroin supply: A rapidly changing risk environment.美国海洛因供应中的芬太尼:迅速变化的风险环境。
Int J Drug Policy. 2017 Aug;46:107-111. doi: 10.1016/j.drugpo.2017.06.010. Epub 2017 Jul 20.
6
Epidemiology of fentanyl-involved drug overdose deaths: A geospatial retrospective study in Rhode Island, USA.芬太尼相关药物过量死亡的流行病学:美国罗德岛的一项地理空间回顾性研究。
Int J Drug Policy. 2017 Aug;46:130-135. doi: 10.1016/j.drugpo.2017.05.029. Epub 2017 Jun 7.
7
"Don't Judge a Book Its Cover": A Qualitative Study of Methadone Patients' Experiences of Stigma.“勿以貌取人”:一项关于美沙酮患者耻辱感经历的定性研究
Subst Abuse. 2017 Mar 23;11:1178221816685087. doi: 10.1177/1178221816685087. eCollection 2017.
8
Peer engagement in harm reduction strategies and services: a critical case study and evaluation framework from British Columbia, Canada.同伴参与减少伤害策略与服务:来自加拿大不列颠哥伦比亚省的一项关键案例研究及评估框架
BMC Public Health. 2016 May 27;16:452. doi: 10.1186/s12889-016-3136-4.
9
Opioid Prescribing for Chronic Pain: Not for the Faint of Heart.慢性疼痛的阿片类药物处方:并非胆小者可为。
JAMA Intern Med. 2016 May 1;176(5):599-601. doi: 10.1001/jamainternmed.2016.0664.
10
CDC Guideline for Prescribing Opioids for Chronic Pain--United States, 2016.美国 2016 年慢性疼痛阿片类药物处方指南。
JAMA. 2016 Apr 19;315(15):1624-45. doi: 10.1001/jama.2016.1464.

疼痛作为物质使用的风险因素:对加拿大不列颠哥伦比亚省吸毒者的定性研究。

Pain as a risk factor for substance use: a qualitative study of people who use drugs in British Columbia, Canada.

机构信息

British Columbia Centre on Substance Use, 400 - 1045 Howe Street, Vancouver, BC, V6Z 2A9, Canada.

School of Population and Public Health, Faculty of Medicine, University of British Columbia, 2206 East Mall, Vancouver, BC, V6Z 1Z3, Canada.

出版信息

Harm Reduct J. 2018 Jul 5;15(1):35. doi: 10.1186/s12954-018-0241-y.

DOI:10.1186/s12954-018-0241-y
PMID:29976203
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC6034304/
Abstract

BACKGROUND

People who use drugs have a significantly higher prevalence of chronic non-cancer pain compared to the general population, yet little is known about how various policy, economic, physical, and social environments may serve as risk or protective factors in the context of concurrent pain and substance use. Therefore, this study sought to explore perspectives, risks, and harms associated with pain among people who use drugs.

METHODS

Thirteen focus group interviews were held across British Columbia, Canada, from July to September 2015. In total, 83 people who had lived experience with substance use participated in the study. Using an interpretive description approach, themes were conceptualized according to the Rhodes' Risk Environment and patient-centered care frameworks.

RESULTS

Participants described how their experiences with inadequately managed pain in various policy, economic, physical, and social environments reinforced marginalization, such as restrictive policies, economic vulnerability, lack of access to socio-physical support systems, stigma from health professionals, and denial of pain medication leading to risky self-medication. Principles of patient-centered care were often not upheld, from a lack of recognition of patients as experts in understanding their unique pain needs and experiences, to an absence of shared power and decision-making, which often resulted in distrust of the patient-provider relationship.

CONCLUSIONS

Various risk environments and non-patient-centered interactions may contribute to an array of health and social harms in the context of inadequately managed pain among people who use drugs.

摘要

背景

与一般人群相比,使用毒品的人患有慢性非癌症疼痛的比例明显更高,但对于各种政策、经济、物理和社会环境如何可能成为同时存在疼痛和物质使用的风险或保护因素,人们知之甚少。因此,本研究旨在探讨与使用毒品者的疼痛相关的观点、风险和危害。

方法

2015 年 7 月至 9 月,在加拿大不列颠哥伦比亚省进行了 13 次焦点小组访谈。共有 83 名有药物使用经历的人参与了这项研究。采用解释性描述方法,根据 Rhodes 的风险环境和以患者为中心的护理框架来概念化主题。

结果

参与者描述了他们在各种政策、经济、物理和社会环境中经历的疼痛管理不善的情况,这些情况加剧了边缘化,例如限制政策、经济脆弱性、缺乏获得社会物理支持系统的机会、卫生专业人员的污名以及拒绝疼痛药物治疗导致的危险自我药物治疗。以患者为中心的护理原则往往没有得到遵守,从缺乏对患者作为理解其独特疼痛需求和体验的专家的认可,到缺乏共同的权力和决策,这往往导致对医患关系的不信任。

结论

在使用毒品者疼痛管理不善的情况下,各种风险环境和非以患者为中心的相互作用可能导致一系列健康和社会危害。